Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

The impact of γ radiation on the bioavailability of Fe(III) minerals for microbial respiration.

Brown AR, Wincott PL, LaVerne JA, Small JS, Vaughan DJ, Pimblott SM, Lloyd JR.

Environ Sci Technol. 2014 Sep 16;48(18):10672-80. doi: 10.1021/es503249r. Epub 2014 Sep 8.

PMID:
25195952
2.

The synthetic triterpenoid (CDDO-Im) inhibits STAT3, as well as IL-17, and improves DSS-induced colitis in mice.

Fitzpatrick LR, Stonesifer E, Small JS, Liby KT.

Inflammopharmacology. 2014 Dec;22(6):341-9. doi: 10.1007/s10787-014-0203-2. Epub 2014 Apr 9.

PMID:
24715223
3.

Alteration of sediments by hyperalkaline K-rich cement leachate: implications for strontium adsorption and incorporation.

Wallace SH, Shaw S, Morris K, Small JS, Burke IT.

Environ Sci Technol. 2013 Apr 16;47(8):3694-700. doi: 10.1021/es3051982. Epub 2013 Apr 1.

PMID:
23510060
4.

Bacillus coagulans GBI-30, 6086 limits the recurrence of Clostridium difficile-Induced colitis following vancomycin withdrawal in mice.

Fitzpatrick LR, Small JS, Greene WH, Karpa KD, Farmer S, Keller D.

Gut Pathog. 2012 Oct 22;4(1):13. doi: 10.1186/1757-4749-4-13.

5.

Vidofludimus inhibits colonic interleukin-17 and improves hapten-induced colitis in rats by a unique dual mode of action.

Fitzpatrick LR, Small JS, Doblhofer R, Ammendola A.

J Pharmacol Exp Ther. 2012 Sep;342(3):850-60. doi: 10.1124/jpet.112.192203. Epub 2012 Jun 12.

PMID:
22691298
6.

Bacillus Coagulans GBI-30 (BC30) improves indices of Clostridium difficile-Induced colitis in mice.

Fitzpatrick LR, Small JS, Greene WH, Karpa KD, Keller D.

Gut Pathog. 2011 Oct 20;3(1):16. doi: 10.1186/1757-4749-3-16.

7.

4SC-101, a novel immunosuppressive drug, inhibits IL-17 and attenuates colitis in two murine models of inflammatory bowel disease.

Fitzpatrick LR, Deml L, Hofmann C, Small JS, Groeppel M, Hamm S, Lemstra S, Leban J, Ammendola A.

Inflamm Bowel Dis. 2010 Oct;16(10):1763-77. doi: 10.1002/ibd.21264.

PMID:
20310011
8.

A new model of chronic hapten-induced colitis in young rats.

Fitzpatrick LR, Meirelles K, Small JS, Puleo FJ, Koltun WA, Cooney RN.

J Pediatr Gastroenterol Nutr. 2010 Mar;50(3):240-50. doi: 10.1097/MPG.0b013e3181cb8f4a.

PMID:
20118800
9.

Parameter and process significance in mechanistic modeling of cellulose hydrolysis.

Rotter BE, Barry DA, Gerhard JI, Small JS.

Bioresour Technol. 2008 Sep;99(13):5738-48. Epub 2007 Dec 4.

PMID:
18055198
10.

Effects of the probiotic formulation VSL#3 on colitis in weanling rats.

Fitzpatrick LR, Hertzog KL, Quatse AL, Koltun WA, Small JS, Vrana K.

J Pediatr Gastroenterol Nutr. 2007 May;44(5):561-70.

PMID:
17460487
11.

Enhanced intestinal expression of the proteasome subunit low molecular mass polypeptide 2 in patients with inflammatory bowel disease.

Fitzpatrick LR, Small JS, Poritz LS, McKenna KJ, Koltun WA.

Dis Colon Rectum. 2007 Mar;50(3):337-48; discussion 348-50.

PMID:
17160513
12.
13.

Preparation and Certification of K-411 Glass Microspheres.

Marinenko RB, Roberson S, Small JS, Thorne BB, Blackburn D, Kauffman D, Leigh S.

Microsc Microanal. 2000 Nov;6(6):542-550.

PMID:
11116303
14.

Characterization by electrospray mass spectrometry of human Ca(2+)-sensitive cytosolic phospholipase A2 produced in baculovirus-infected insect cells.

Becker GW, Miller JR, Kovacevic S, Ellis RM, Louis AI, Small JS, Stark DH, Roberts EF, Wyrick TK, Hoskins J, et al.

Biotechnology (N Y). 1994 Jan;12(1):69-74.

PMID:
7764328
15.

beta-Amyloid peptide in vitro toxicity: lot-to-lot variability.

May PC, Gitter BD, Waters DC, Simmons LK, Becker GW, Small JS, Robison PM.

Neurobiol Aging. 1992 Sep-Oct;13(5):605-7.

PMID:
1281290

Supplemental Content

Loading ...
Support Center